BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

664 related articles for article (PubMed ID: 30342071)

  • 1. The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions.
    Dunlop BW; Wong A
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():361-379. PubMed ID: 30342071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of HPA-axis function in posttraumatic stress disorder: pharmacological and non-pharmacological challenge tests, a review.
    de Kloet CS; Vermetten E; Geuze E; Kavelaars A; Heijnen CJ; Westenberg HG
    J Psychiatr Res; 2006 Sep; 40(6):550-67. PubMed ID: 16214171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of hypothalamic-pituitary-adrenal axis functioning in posttraumatic stress disorder.
    Jones T; Moller MD
    J Am Psychiatr Nurses Assoc; 2011; 17(6):393-403. PubMed ID: 22142976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder.
    Yehuda R; Giller EL; Southwick SM; Lowy MT; Mason JW
    Biol Psychiatry; 1991 Nov; 30(10):1031-48. PubMed ID: 1661614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of comorbidity and trauma exposure and its timing in shaping HPA axis patterns in depression.
    Mayer SE; Peckins M; Kuhlman KR; Rajaram N; Lopez-Duran NL; Young EA; Abelson JL
    Psychoneuroendocrinology; 2020 Oct; 120():104776. PubMed ID: 32593866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abuse-related posttraumatic stress disorder and alterations of the hypothalamic-pituitary-adrenal axis in women with chronic pelvic pain.
    Heim C; Ehlert U; Hanker JP; Hellhammer DH
    Psychosom Med; 1998; 60(3):309-18. PubMed ID: 9625218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic-pituitary-adrenal axis activity in post-traumatic stress disorder and cocaine use disorder.
    Hadad NA; Schwendt M; Knackstedt LA
    Stress; 2020 Nov; 23(6):638-650. PubMed ID: 32835581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between hypothalamic-pituitary-adrenal axis gene polymorphisms and posttraumatic stress disorder symptoms.
    Zhang K; Wang L; Li G; Cao C; Fang R; Liu P; Luo S; Zhang X
    Horm Behav; 2020 Jan; 117():104604. PubMed ID: 31655035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology of posttraumatic stress disorder.
    Yehuda R
    J Clin Psychiatry; 2001; 62 Suppl 17():41-6. PubMed ID: 11495096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical depression and non-atypical depression: Is HPA axis function a biomarker? A systematic review.
    Juruena MF; Bocharova M; Agustini B; Young AH
    J Affect Disord; 2018 Jun; 233():45-67. PubMed ID: 29150144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adulthood trauma and HPA-axis functioning in healthy subjects and PTSD patients: a meta-analysis.
    Klaassens ER; Giltay EJ; Cuijpers P; van Veen T; Zitman FG
    Psychoneuroendocrinology; 2012 Mar; 37(3):317-31. PubMed ID: 21802212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypothalamic-pituitary-adrenal axis activity and sleep in posttraumatic stress disorder.
    Otte C; Lenoci M; Metzler T; Yehuda R; Marmar CR; Neylan TC
    Neuropsychopharmacology; 2005 Jun; 30(6):1173-80. PubMed ID: 15714228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and hypothalamic pituitary adrenal axis responses to metyrapone in posttraumatic stress disorder.
    Inslicht SS; Rao MN; Richards A; O'Donovan A; Gibson CJ; Baum T; Metzler TJ; Neylan TC
    Psychoneuroendocrinology; 2018 Feb; 88():136-143. PubMed ID: 29268182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine response to CRF stimulation in veterans with and without PTSD in consideration of war zone era.
    Golier JA; Caramanica K; Yehuda R
    Psychoneuroendocrinology; 2012 Mar; 37(3):350-7. PubMed ID: 21813244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological factors of post-traumatic stress: neuroendocrine aspects].
    Birmes P; Escande M; Gourdy P; Schmitt L
    Encephale; 2000; 26(6):55-61. PubMed ID: 11217539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids and Hippocampal Structure and Function in PTSD.
    Szeszko PR; Lehrner A; Yehuda R
    Harv Rev Psychiatry; 2018; 26(3):142-157. PubMed ID: 29734228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticotropin-releasing hormone and the hypothalamic-pituitary-adrenal axis in psychiatric disease.
    Naughton M; Dinan TG; Scott LV
    Handb Clin Neurol; 2014; 124():69-91. PubMed ID: 25248580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A combined dexamethasone/corticotropin-releasing hormone test in patients with chronic PTSD--first preliminary results.
    Muhtz C; Wester M; Yassouridis A; Wiedemann K; Kellner M
    J Psychiatr Res; 2008 Jul; 42(8):689-93. PubMed ID: 17884095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HPA- and HPT-axis alterations in chronic posttraumatic stress disorder.
    Olff M; Güzelcan Y; de Vries GJ; Assies J; Gersons BP
    Psychoneuroendocrinology; 2006 Nov; 31(10):1220-30. PubMed ID: 17081699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine aspects of post-traumatic stress disorder and implications for diagnosis and treatment.
    Daskalakis NP; Lehrner A; Yehuda R
    Endocrinol Metab Clin North Am; 2013 Sep; 42(3):503-13. PubMed ID: 24011883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.